{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:29:39Z","timestamp":1761647379054,"version":"3.44.0"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["advancesinpediatrics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Pediatrics"],"published-print":{"date-parts":[[2005]]},"DOI":"10.1016\/j.yapd.2005.03.005","type":"journal-article","created":{"date-parts":[[2005,11,28]],"date-time":"2005-11-28T09:52:34Z","timestamp":1133171554000},"page":"129-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Meningococcal Infections at the Start of the 21st Century"],"prefix":"10.1016","volume":"52","author":[{"given":"Petter","family":"Brandtzaeg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"van Deuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yapd.2005.03.005_bib1","first-page":"163","article-title":"M\u00e9moire sur la maladie qui r\u00e9gn\u00e9 a Gen\u00e8ve au printemps de 1805","volume":"11","author":"Vieusseux","year":"1805","journal-title":"J Med Chir Pharm"},{"key":"10.1016\/j.yapd.2005.03.005_bib2","first-page":"65","article-title":"The history of a singular and very mortal disease which lately made its appearance in Medfield","volume":"1","author":"Danielson","year":"1806","journal-title":"Med Agric Reg"},{"key":"10.1016\/j.yapd.2005.03.005_bib3","first-page":"573","article-title":"Ueber die Aetiologie der akuten Meningitis cerebrospinalis","volume":"5","author":"Weichselbaum","year":"1887","journal-title":"Fortsch Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/jmm.0.45529-0","article-title":"Neisseria meningitidis: An overview of the carriage state","volume":"53","author":"Yazdankhah","year":"2004","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.yapd.2005.03.005_bib5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/35006655","article-title":"Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491","volume":"404","author":"Parkhill","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.yapd.2005.03.005_bib6","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1126\/science.287.5459.1809","article-title":"Complete genome sequence of Neisseria meningitidis serogroup B strain MC58","volume":"287","author":"Tettelin","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.yapd.2005.03.005_bib7","series-title":"Endotoxin in Health and Disease","first-page":"93","article-title":"Chemical structure of lipid A: Recent advances in structural analysis of biologically active molecules","author":"Z\u00e4hringer","year":"1999"},{"key":"10.1016\/j.yapd.2005.03.005_bib8","first-page":"167","article-title":"Bacterial lipopolysaccharides and innate immunity","volume":"7","author":"Alexander","year":"2001","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.yapd.2005.03.005_bib9","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1128\/jb.174.6.1793-1800.1992","article-title":"Structural characterization of the lipid A component of pathogenic Neisseria meningitidis","volume":"174","author":"Kulshin","year":"1992","journal-title":"J Bacteriol"},{"key":"10.1016\/j.yapd.2005.03.005_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/IAI.72.1.371-380.2004","article-title":"Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14\/Toll-like receptor 4 pathway","volume":"72","author":"Zughaier","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.yapd.2005.03.005_bib11","series-title":"Endotoxin in Health and Disease","first-page":"179","article-title":"The chemistry and biology of lipooligosaccharides: The endotoxins of bacteria of the respiratory and genital mucosa","author":"Mcleod Griffiss","year":"1999"},{"key":"10.1016\/j.yapd.2005.03.005_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/10408419891294216","article-title":"Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin)","volume":"24","author":"Kahler","year":"1998","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.yapd.2005.03.005_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0882-4010(92)90022-G","article-title":"The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis","volume":"13","author":"Jones","year":"1992","journal-title":"Microb Pathog"},{"key":"10.1016\/j.yapd.2005.03.005_bib14","series-title":"Endotoxin in Health and Disease","first-page":"39","article-title":"Lipopolysaccharide phase variation in Haemophilus and Neisseria","author":"Hood","year":"1999"},{"key":"10.1016\/j.yapd.2005.03.005_bib15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1099\/00222615-41-4-236","article-title":"Lipooligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies","volume":"41","author":"Scholten","year":"1994","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.yapd.2005.03.005_bib16","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1128\/iai.64.8.2998-3006.1996","article-title":"Invasion of primary nasopharyngeal epithelial cells by Neisseria meningitidis is controlled by phase variation of multiple surface antigens","volume":"64","author":"de Vries","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.yapd.2005.03.005_bib17","series-title":"Endotoxin in Health and Disease","first-page":"55","article-title":"Antigenic mimicry in Neisseria species","author":"Giardina","year":"1999"},{"key":"10.1016\/j.yapd.2005.03.005_bib18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/clinids\/7.4.504","article-title":"Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes","volume":"7","author":"Frasch","year":"1985","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01963104","article-title":"Outer membrane protein serosubtyping of Neisseria meningitidis","volume":"7","author":"Poolman","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib20","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.yapd.2005.03.005_bib21","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1046\/j.1365-2958.1997.4841857.x","article-title":"Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria","volume":"25","author":"Kallstrom","year":"1997","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.yapd.2005.03.005_bib22","doi-asserted-by":"crossref","first-page":"21777","DOI":"10.1074\/jbc.273.34.21777","article-title":"Cell signaling by the type IV pili of pathogenic Neisseria","volume":"273","author":"Kallstrom","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yapd.2005.03.005_bib23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1462-5822.2004.00393.x","article-title":"Epithelial cell responses induced upon adherence of pathogenic Neisseria","volume":"6","author":"Plant","year":"2004","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.yapd.2005.03.005_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1699-0463.1998.tb01379.x","article-title":"Population genetics and molecular epidemiology of Neisseria meningitidis","volume":"106","author":"Caugant","year":"1998","journal-title":"APMIS"},{"key":"10.1016\/j.yapd.2005.03.005_bib25","series-title":"Meningococcal Disease, Methods and Protocols","first-page":"341","article-title":"Epidemiology of meningococcal disease in North America","author":"Pollard","year":"2001"},{"key":"10.1016\/j.yapd.2005.03.005_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.med.55.091902.103612","article-title":"Opportunities for control of meningococcal disease in the United States","volume":"55","author":"Raghunathan","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1385\/MB:18:2:119","article-title":"Molecular techniques for the investigation of meningococcal disease epidemiology","volume":"18","author":"Maiden","year":"2001","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.yapd.2005.03.005_bib28","series-title":"Meningococcal Disease","first-page":"115","article-title":"Meningococcal carriage and disease","author":"Cartwright","year":"1995"},{"key":"10.1016\/j.yapd.2005.03.005_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/clinids\/13.1.22","article-title":"Pathogenic events during infection of the human nasopharynx with Neisseria meningitidis and Haemophilus influenzae","volume":"13","author":"Stephens","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1099\/00222615-42-5-353","article-title":"Experimental infection of human nasal mucosal explants with Neisseria meningitidis","volume":"42","author":"Read","year":"1995","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.yapd.2005.03.005_bib31","first-page":"201","article-title":"Infection, fever, and exogenous and endogenous pyrogens: Some concepts have changed","volume":"10","author":"Dinarello","year":"2004","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.yapd.2005.03.005_bib32","first-page":"401","article-title":"Neisseria meningitidis lipopolysaccharides in human pathology","volume":"7","author":"Brandtzaeg","year":"2001","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.yapd.2005.03.005_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/infdis\/159.2.195","article-title":"Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease","volume":"159","author":"Brandtzaeg","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib34","series-title":"Meningococcal Disease, Methods and Protocols","first-page":"427","article-title":"Quantitative detection of bacterial lipopolysaccharides in clinical specimen","author":"Brandtzaeg","year":"2001"},{"key":"10.1016\/j.yapd.2005.03.005_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/33046","article-title":"Meningitis bacterium is viable without endotoxin","volume":"392","author":"Steeghs","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.yapd.2005.03.005_bib36","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1365-2249.2000.01409.x","article-title":"Gram-negative bacteria induce proinflammatory cytokine production by monocytes in the absence of lipopolysaccharide (LPS)","volume":"122","author":"Uronen","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.yapd.2005.03.005_bib37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/09680519030090020901","article-title":"Lessons from an LPS-deficient Neisseria meningitidis mutant","volume":"9","author":"van der Ley","year":"2003","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.yapd.2005.03.005_bib38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1586\/14787210.1.4.589","article-title":"Host response to Neisseria meningitidis lacking lipopolysaccharides","volume":"1","author":"Brandtzaeg","year":"2003","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.yapd.2005.03.005_bib39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/09680519000060050301","article-title":"Differential roles of TLR2 and TLR4 in the host response to Gram-negative bacteria: Lessons from a lipopolysaccharide-deficient mutant of Neisseria meningitidis","volume":"6","author":"Ingalls","year":"2000","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.yapd.2005.03.005_bib40","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1128\/IAI.69.4.2230-2236.2001","article-title":"Membrane-associated proteins of a lipopolysaccharide-deficient mutant of Neisseria meningitidis activate the inflammatory response through toll-like receptor 2","volume":"69","author":"Ingalls","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.yapd.2005.03.005_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1086\/317647","article-title":"A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via toll-like receptor (TLR) 2 but not via TLR4\/MD2","volume":"183","author":"Pridmore","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1189\/jlb.70.2.283","article-title":"Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response","volume":"70","author":"Sprong","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.yapd.2005.03.005_bib43","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1086\/515163","article-title":"Endotoxin interactions with lipopolysaccharide-responsive cells","volume":"28","author":"Tobias","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.smim.2003.10.007","article-title":"Endotoxin recognition molecules, Toll-like receptor 4-MD-2","volume":"16","author":"Miyake","year":"2004","journal-title":"Semin Immunol"},{"key":"10.1016\/j.yapd.2005.03.005_bib45","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.yapd.2005.03.005_bib46","first-page":"BR316","article-title":"Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis","volume":"9","author":"Mirlashari","year":"2003","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.yapd.2005.03.005_bib47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/09680519030090030301","article-title":"Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex","volume":"9","author":"Bjerre","year":"2003","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.yapd.2005.03.005_bib48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/infdis\/160.1.58","article-title":"Complement activation and endotoxin levels in systemic meningococcal disease","volume":"160","author":"Brandtzaeg","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1086\/338269","article-title":"Complement activation induced by purified Neisseria meningitidis lipopolysaccharide (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant","volume":"185","author":"Bjerre","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib50","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1128\/IAI.72.6.3344-3349.2004","article-title":"Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide","volume":"72","author":"Sprong","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.yapd.2005.03.005_bib51","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/infdis\/173.3.647","article-title":"The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation","volume":"173","author":"Brandtzaeg","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib52","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1182\/blood-2003-03-0703","article-title":"Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis","volume":"102","author":"Sprong","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.yapd.2005.03.005_bib53","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1128\/IAI.66.11.5350-5356.1998","article-title":"Complement activation in relation to capillary leakage in children with septic shock and purpura","volume":"66","author":"Hazelzet","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.yapd.2005.03.005_bib54","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(03)00740-0","article-title":"Host genetic determinants of Neisseria meningitidis infections","volume":"3","author":"Emonts","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib55","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/adc.86.1.44","article-title":"Meningococcal bacterial DNA load at presentation correlates with disease severity","volume":"86","author":"Hackett","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yapd.2005.03.005_bib56","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1128\/JCM.42.7.2980-2987.2004","article-title":"Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease","volume":"42","author":"Ovstebo","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.yapd.2005.03.005_bib57","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/CMR.13.1.144","article-title":"Update on meningococcal disease with emphasis on pathogenesis and clinical management","volume":"13","author":"van Deuren","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.yapd.2005.03.005_bib58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0966-842X(02)02349-1","article-title":"How do extracellular pathogens cross the blood-brain barrier?","volume":"10","author":"Nassif","year":"2002","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.yapd.2005.03.005_bib59","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/infdis\/166.3.650","article-title":"Compartmentalization of lipopolysaccharide production correlates with clinical presentation in meningococcal disease","volume":"166","author":"Brandtzaeg","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib60","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1056\/NEJMcpc030033","article-title":"Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 38-2003. A 12-year-old girl with fever and coma","volume":"349","author":"Warren","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1542\/peds.80.1.63","article-title":"Neisseria meningitidis bacteremia in children: Quantitation of bacteremia and spontaneous clinical recovery without antibiotic therapy","volume":"80","author":"Sullivan","year":"1987","journal-title":"Pediatrics"},{"key":"10.1016\/j.yapd.2005.03.005_bib62","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1055\/s-0038-1649961","article-title":"Activation of the intrinsic pathway of coagulation in children with meningococcal septic shock","volume":"74","author":"Wuillemin","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.yapd.2005.03.005_bib63","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1097\/01.CCM.0000126123.34119.98","article-title":"Human models of endotoxemia and recombinant human activated protein C","volume":"32","author":"O'Brien","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0038-1651669","article-title":"Coagulation activation and tissue necrosis in meningococcal septic shock: Severely reduced protein C levels predict a high mortality","volume":"73","author":"Fijnvandraat","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.yapd.2005.03.005_bib65","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1182\/blood-2003-02-0416","article-title":"Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia","volume":"102","author":"Derhaschnig","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.yapd.2005.03.005_bib66","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib67","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-065X.1992.tb01416.x","article-title":"Different role of cytokine mediators in septic shock related to meningococcal disease and surgery\/polytrauma","volume":"127","author":"Waage","year":"1992","journal-title":"Immunol Rev"},{"key":"10.1016\/j.yapd.2005.03.005_bib68","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.CCM.0000104950.52577.97","article-title":"Plasma interferon-gamma and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic gram-positive septic shock","volume":"32","author":"Bjerre","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib69","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1182\/blood-2004-03-1203","article-title":"Patients with severe sepsis vary markedly in their ability to generate activated protein C","volume":"104","author":"Liaw","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.yapd.2005.03.005_bib70","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/01.CCM.0000072121.61120.D8","article-title":"Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: A randomized, double-blinded, placebo-controlled, dose-finding study","volume":"31","author":"de Kleijn","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib71","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1097\/01.CCM.0000126120.49367.AC","article-title":"Severe protein C deficiency predicts early death in severe sepsis","volume":"32","author":"Macias","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib72","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0895-4356(98)00064-X","article-title":"Outcome of pre-hospital antibiotic treatment of meningococcal disease","volume":"51","author":"Sorensen","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.yapd.2005.03.005_bib73","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1182\/blood.V96.12.3719","article-title":"An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia","volume":"96","author":"White","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.yapd.2005.03.005_bib74","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1542\/peds.103.2.e20","article-title":"Clinical and hematologic features do not reliably identify children with unsuspected meningococcal disease","volume":"103","author":"Kuppermann","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.yapd.2005.03.005_bib75","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1542\/peds.110.1.e3","article-title":"Extremity pain and refusal to walk in children with invasive meningococcal disease","volume":"110","author":"Inkelis","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.yapd.2005.03.005_bib76","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/adc.85.2.160","article-title":"Diagnostic assessment of haemorrhagic rash and fever","volume":"85","author":"Nielsen","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yapd.2005.03.005_bib77","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/adc.85.3.218","article-title":"The child with a non-blanching rash: How likely is meningococcal disease?","volume":"85","author":"Wells","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yapd.2005.03.005_bib79","series-title":"Meningococcal Disease, Methods and Protocols","first-page":"411","article-title":"Clinical scoring systems in meningococcal disease","author":"Festa","year":"2001"},{"key":"10.1016\/j.yapd.2005.03.005_bib80","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/513759","article-title":"Meningococcal septic shock in children: Clinical and laboratory features, outcome, and development of a prognostic score","volume":"25","author":"Kornelisse","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib81","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00130478-200107000-00007","article-title":"Early severe neutropenia and thrombocytopenia identifies the highest risk cases of severe meningococcal disease","volume":"2","author":"Peters","year":"2001","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib82","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/BF01701486","article-title":"Severity scores in meningococcal septicemia and severe infectious purpura with shock","volume":"21","author":"Leclerc","year":"1995","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib83","series-title":"Meningococcal Disease","first-page":"207","article-title":"Treatment of meningococcal disease in childhood","author":"Nadel","year":"1995"},{"key":"10.1016\/j.yapd.2005.03.005_bib84","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/adc.80.3.290","article-title":"Emergency management of meningococcal disease","volume":"80","author":"Pollard","year":"1999","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yapd.2005.03.005_bib85","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/adc.88.7.608","article-title":"Treatment of meningococcal infection","volume":"88","author":"Welch","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yapd.2005.03.005_bib86","series-title":"Meningococal Disease. Methods and Protocols","first-page":"549","article-title":"Evaluation of new treatment in meningococcal disease","author":"Nadel","year":"2001"},{"key":"10.1016\/j.yapd.2005.03.005_bib87","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/adc.85.5.386","article-title":"Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery","volume":"85","author":"Booy","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yapd.2005.03.005_bib88","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/bmj.327.7415.596","article-title":"Case fatality rates for meningococcal disease in an English population, 1963-98: Database study","volume":"327","author":"Goldacre","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.yapd.2005.03.005_bib89","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1542\/peds.108.5.1169","article-title":"Lumbar puncture in pediatric bacterial meningitis: Defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment","volume":"108","author":"Kanegaye","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.yapd.2005.03.005_bib90","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/bmj.306.6887.1229","article-title":"Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions","volume":"306","author":"van Deuren","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.yapd.2005.03.005_bib91","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJM199703063361007","article-title":"Treatment of bacterial meningitis","volume":"336","author":"Quagliarello","year":"1997","journal-title":"N Eng J Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib92","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1086\/377203","article-title":"Three days of intravenous benzyl penicillin treatment of meningococcal disease in adults","volume":"37","author":"Ellis-Pegler","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib93","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0891-5520(05)70100-8","article-title":"Early management of meningococcal disease","volume":"13","author":"Cartwright","year":"1999","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.yapd.2005.03.005_bib94","series-title":"Meningococcal Disease. Methods and Protocols","first-page":"459","article-title":"Cytokine measurement in vivo and in vitro","author":"van Deuren","year":"2001"},{"key":"10.1016\/j.yapd.2005.03.005_bib95","series-title":"Meningococcal Disease. Methods and Protocols","first-page":"23","article-title":"PCR diagnosis","author":"Guiver","year":"2001"},{"key":"10.1016\/j.yapd.2005.03.005_bib96","series-title":"Meningococcal Disease. Methods and Protocols","first-page":"41","article-title":"Detection of meningococcal antigen by latex agglutination","author":"Sobanski","year":"2001"},{"key":"10.1016\/j.yapd.2005.03.005_bib97","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0196-0644(89)80213-6","article-title":"Analysis of emergency department management of suspected bacterial meningitis","volume":"18","author":"Talan","year":"1989","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib98","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0033-3506(96)80109-0","article-title":"How long is too long? Determining the early management of meningococcal disease in Birmingham","volume":"110","author":"Wood","year":"1996","journal-title":"Public Health"},{"key":"10.1016\/j.yapd.2005.03.005_bib99","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/emj.18.3.162","article-title":"Improving promptness of antibiotic treatment in meningococcal disease","volume":"18","author":"Riordan","year":"2001","journal-title":"Emerg Med J"},{"key":"10.1016\/j.yapd.2005.03.005_bib100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1302\/0301-620X.82B3.0820383","article-title":"The orthopaedic management of peripheral ischaemia in meningococcal septicaemia in children","volume":"82","author":"Davies","year":"2000","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.yapd.2005.03.005_bib101","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/BF03349613","article-title":"Hypoglycemia, hormones and cytokines in fatal meningococcal septicemia","volume":"13","author":"Romijn","year":"1990","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.yapd.2005.03.005_bib102","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/adc.83.6.510","article-title":"Hypocalcaemia in severe meningococcal infections","volume":"83","author":"Baines","year":"2000","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yapd.2005.03.005_bib103","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1086\/517026","article-title":"Rhabdomyolysis during the subacute stage of meningococcal sepsis","volume":"26","author":"van Deuren","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib104","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/clind\/15.3.424","article-title":"Plasma and whole blood exchange in meningococcal sepsis","volume":"15","author":"van Deuren","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0140-6736(96)90389-X","article-title":"Early haemo-diafiltration in meningococcal septicaemia","volume":"347","author":"Best","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.yapd.2005.03.005_bib106","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/s001340000583","article-title":"Hemofiltration in septic patients is not able to alter the plasma concentration of cytokines therapeutically","volume":"26","author":"van Deuren","year":"2000","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib107","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00000637-199509000-00014","article-title":"Successful use of leeches in the treatment of purpura fulminans","volume":"35","author":"de Chalain","year":"1995","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.yapd.2005.03.005_bib108","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/00003246-199706000-00028","article-title":"Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans","volume":"25","author":"Aiuto","year":"1997","journal-title":"Crit Care Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib109","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00003246-200002000-00066","article-title":"Is recombinant tissue plasminogen activator an option in the treatment of meningococcus-induced purpura?","volume":"28","author":"Veldman","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib110","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/01.CCM.0000133667.86429.5D","article-title":"Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: A retrospective study","volume":"32","author":"Zenz","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib111","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1542\/peds.113.1.7","article-title":"Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis","volume":"113","author":"Barton","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.yapd.2005.03.005_bib112","first-page":"119","article-title":"Meningococcal infections: A review of 200 fatal cases","volume":"26","author":"Hardman","year":"1967","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.yapd.2005.03.005_bib113","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1067\/mpa.2002.124648","article-title":"Retinal hemorrhages in meningococcal septicemia","volume":"6","author":"Dinakaran","year":"2002","journal-title":"J AAPOS"},{"key":"10.1016\/j.yapd.2005.03.005_bib114","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0049-3848(90)90326-8","article-title":"Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease","volume":"57","author":"Brandtzaeg","year":"1990","journal-title":"Thromb Res"},{"key":"10.1016\/j.yapd.2005.03.005_bib115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02575306","article-title":"Meningococcemia and purpura fulminans in adults: Acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates","volume":"16","author":"Fourrier","year":"1990","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib116","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s004310051032","article-title":"Are there specific haemostatic abnormalities in children surviving septic shock with purpura and having skin necrosis or limb ischaemia that need skin grafts or limb amputations?","volume":"158","author":"Cremer","year":"1999","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.yapd.2005.03.005_bib117","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00006454-199410000-00004","article-title":"The role of heparin in the prevention of extremity and digit necrosis in meningococcal purpura fulminans","volume":"13","author":"Kuppermann","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.yapd.2005.03.005_bib118","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00134-003-1784-1","article-title":"Combined antithrombin and protein C supplementation in meningococcal purpura fulminans: A pharmacokinetic study","volume":"29","author":"Fourrier","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib119","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: A randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.yapd.2005.03.005_bib120","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.290.2.238","article-title":"Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: A randomized controlled trial","volume":"290","author":"Abraham","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.yapd.2005.03.005_bib121","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0037-1615840","article-title":"Endothelial protein C receptor","volume":"82","author":"Esmon","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.yapd.2005.03.005_bib122","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/00006454-199910000-00011","article-title":"Effect of the factor V Leiden mutation on the severity of meningococcal disease","volume":"18","author":"Kondaveeti","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.yapd.2005.03.005_bib123","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJM200108093450603","article-title":"Dysfunction of endothelial protein C activation in severe meningococcal sepsis","volume":"345","author":"Faust","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib124","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/cc2167","article-title":"Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis","volume":"7","author":"Bernard","year":"2003","journal-title":"Crit Care"},{"key":"10.1016\/j.yapd.2005.03.005_bib125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s001340050538","article-title":"A normal platelet count at admission in acute meningococcal disease does not exclude a fulminant course","volume":"24","author":"van Deuren","year":"1998","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib126","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/00003246-199910000-00032","article-title":"Admission cortisol and adrenocorticotrophic hormone levels in children with meningococcal disease: Evidence of adrenal insufficiency?","volume":"27","author":"Riordan","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.yapd.2005.03.005_bib127","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00006454-200204000-00013","article-title":"Low serum cortisol in combination with high adrenocorticotrophic hormone concentrations are associated with poor outcome in children with severe meningococcal disease","volume":"21","author":"de Kleijn","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.yapd.2005.03.005_bib128","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1210\/jcem.85.10.6901","article-title":"Endocrine and metabolic responses in children with meningoccocal sepsis: Striking differences between survivors and nonsurvivors","volume":"85","author":"Joosten","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2005.03.005_bib129","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1086\/324673","article-title":"Adrenocorticotropic hormone and cortisol levels in relation to inflammatory response and disease severity in children with meningococcal disease","volume":"184","author":"van Woensel","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib130","series-title":"Yearbook of Intensive Care","first-page":"100","article-title":"Acute adrenal insufficiency in critically ill patients: The Waterhouse-Friderichsen syndrome revisited","author":"van Deuren","year":"2001"},{"key":"10.1016\/j.yapd.2005.03.005_bib131","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1460-9592.1998.00278.x","article-title":"Haemodynamic improvement in a child with meningococcal sepsis following methylprednisolone: Restoration of beta-adrenergic receptor responsiveness?","volume":"8","author":"O'Brien","year":"1998","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.yapd.2005.03.005_bib132","first-page":"82","article-title":"Does early administration of dexamethasone improve neurological outcome in children with meningococcal meningitis?","volume":"89","author":"Gupta","year":"2004","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yapd.2005.03.005_bib133","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1365-2044.2004.03748.x","article-title":"Intracranial pressure measurement, induced hypothermia and barbiturate coma in meningitis associated with intractable raised intracranial pressure","volume":"59","author":"Cuthbertson","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1016\/j.yapd.2005.03.005_bib134","first-page":"513","article-title":"Immune complexes and the pathogenesis of meningococcal arthritis","volume":"59","author":"Greenwood","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.yapd.2005.03.005_bib135","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.inf.0000115951.41873.07","article-title":"Pericarditis after meningococcal infection: Case report of a child with two distinct episodes","volume":"23","author":"El Bashir","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.yapd.2005.03.005_bib136","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1053\/jpsu.2003.50130","article-title":"Surgical interventions in children with meningococcal purpura fulminans: A review of 117 procedures in 21 children","volume":"38","author":"Wheeler","year":"2003","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.yapd.2005.03.005_bib137","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bjps.2003.11.016","article-title":"Imaging to guide amputation of necrotic limbs in paediatric patients with meningococcal septicaemia","volume":"57","author":"Harley","year":"2004","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.yapd.2005.03.005_bib138","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.20059","article-title":"Meningitis-associated hearing loss: Protection by adjunctive antioxidant therapy","volume":"55","author":"van de Beek","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yapd.2005.03.005_bib139","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/00365540110080179","article-title":"Sequelae after bacterial meningitis in childhood","volume":"34","author":"Oostenbrink","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib140","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s00431-002-0957-1","article-title":"Long-term follow-up of children with bacterial meningitis with emphasis on behavioural characteristics","volume":"161","author":"Berg","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.yapd.2005.03.005_bib141","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1136\/bmj.328.7452.1339","article-title":"Effectiveness of antibiotics in preventing meningococcal disease after a case: Systematic review","volume":"328","author":"Purcell","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.yapd.2005.03.005_bib142","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0140-6736(00)03163-9","article-title":"Risk of secondary meningococcal disease in health-care workers","volume":"356","author":"Gilmore","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.yapd.2005.03.005_bib143","series-title":"Red Book: 2003 Report of the Committee on Infectious Diseases","first-page":"430","article-title":"Meningococcal infections","author":"American Academy of Pediatrics","year":"2003"},{"key":"10.1016\/j.yapd.2005.03.005_bib144","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/01.inf.0000091283.10199.dc","article-title":"Age dependence of in vitro survival of meningococci in whole blood during childhood","volume":"22","author":"Ison","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.yapd.2005.03.005_bib145","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000070219","article-title":"Antibody-dependent killing of meningococci by human neutrophils in serum of late complement component-deficient patients","volume":"130","author":"Platonov","year":"2003","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.yapd.2005.03.005_bib146","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1086\/317667","article-title":"Immunologic memory 5 years after meningococcal A\/C conjugate vaccination in infancy","volume":"183","author":"MacLennan","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib147","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1473-3099(04)01251-4","article-title":"Meningococcal polysaccharide-protein conjugate vaccines","volume":"5","author":"Snape","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib148","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination","volume":"359","author":"Maiden","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.yapd.2005.03.005_bib149","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(92)93086-3","article-title":"Protective efficacy of a serogroup B meningococcal vaccine in San Paulo, Brazil","volume":"340","author":"de Moreas","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.yapd.2005.03.005_bib150","doi-asserted-by":"crossref","first-page":"S293","DOI":"10.1097\/01.inf.0000147645.53942.00","article-title":"The strategy to control New Zealand's epidemic of group B meningococcal disease","volume":"23","author":"O'Hallahan","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.yapd.2005.03.005_bib151","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0264-410X(01)00371-1","article-title":"Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine","volume":"20","author":"de Kleijn","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.yapd.2005.03.005_bib152","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/infdis\/165.4.695","article-title":"Treatment of severe infectious purpura in children with plasma from donors immunized with Escherichia coli J5: A prospective double-blind study","volume":"165","author":"The J5 Study Group","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib153","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/515184","article-title":"Randomized placebo-controlled trial of HA-1A, a human monoclonal anti-endotoxin antibody, in children with meningococcal septic shock","volume":"28","author":"Derkx","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.yapd.2005.03.005_bib154","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0140-6736(00)02712-4","article-title":"Recombinant bactericidal\/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: A randomised trial","volume":"356","author":"Levin","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.yapd.2005.03.005_bib155","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0140-6736(00)02705-7","article-title":"Parents' and GPs' key role in diagnosis of meningococcal septicaemia","volume":"356","author":"van Deuren","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.yapd.2005.03.005_bib156","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood.V87.6.2337.bloodjournal8762337","article-title":"Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase","volume":"87","author":"Jansen","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.yapd.2005.03.005_bib78","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00431-002-1024-7","article-title":"Prospective validation of the Glasgow Meningococcal Septicaemia Prognostic Score. Comparison with other scoring methods","volume":"161","author":"Riordan","year":"2002","journal-title":"Eur J Pediatr"}],"container-title":["Advances in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S006531010500006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S006531010500006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T20:05:50Z","timestamp":1758744350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S006531010500006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":156,"alternative-id":["S006531010500006X"],"URL":"https:\/\/doi.org\/10.1016\/j.yapd.2005.03.005","relation":{},"ISSN":["0065-3101"],"issn-type":[{"type":"print","value":"0065-3101"}],"subject":[],"published":{"date-parts":[[2005]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meningococcal Infections at the Start of the 21st Century","name":"articletitle","label":"Article Title"},{"value":"Advances in Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yapd.2005.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}